Martin Marietta (MLM) Reports Next Week: Wall Street Expects Earnings Growth

Martin Marietta (MLM) is scheduled to report earnings for the quarter ended June 2025 on August 7, with consensus estimates projecting EPS of $5.30 (+0.8% YoY) on revenues of $1.88 billion (+6.5% YoY). Despite a recent 0.45% downward revision in consensus EPS estimates, Zacks' analysis, combining a positive Earnings ESP of +0.20% and a Zacks Rank #3, indicates a high likelihood of MLM beating consensus EPS expectations. While the company has a mixed history of earnings surprises, this combination positions MLM as a compelling earnings-beat candidate, though investors should consider other factors beyond the report itself.

Analysis

Martin Marietta (MLM) is approaching its Q2 2025 earnings release with conflicting signals for investors. The Wall Street consensus projects year-over-year revenue growth of 6.5% to $1.88 billion, but a nearly flat earnings per share (EPS) increase of only 0.8% to $5.30, suggesting potential margin compression. While the consensus EPS estimate has been revised downward by 0.45% over the last 30 days, a more recent proprietary indicator, the Zacks Earnings ESP, is positive at +0.20%. This, combined with a Zacks Rank of #3 (Hold), creates a statistical model that indicates a high likelihood of an EPS beat. However, this forward-looking model is contrasted by the company's recent performance history, which includes an earnings miss of -2.06% in the last reported quarter and only one consensus EPS beat over the last four quarters. This creates a scenario where quantitative indicators point to a positive surprise, but historical precedent and broader analyst revisions inject a significant degree of caution.

Key Decisions for Investors

• Given the positive +0.20% Earnings ESP and Zacks Rank #3, a short-term bullish stance could be considered, as these factors historically predict an earnings beat with high probability.
• Investors should exercise caution due to the company's poor track record of meeting expectations, having beaten EPS estimates only once in the last four quarters, and the recent downward revision in the 30-day consensus estimate.
• Pay close attention to management's commentary on the earnings call to understand the significant divergence between the 6.5% revenue growth and 0.8% EPS growth forecasts, as this will be critical for assessing margin health and the stock's future trajectory beyond the initial earnings reaction.